Buy Dr Reddy’s Laboratories, target Rs 2822: Hadrien Mendonca

Momentum oscillators indicate that the stock has the potential to move higher towards its target of Rs 2822 in the near-term.

Moneycontrol Contributor

January 25, 2019 / 11:17 IST

Praveg Communications (India) Ltd.

26 Aug, 2025 12:21

Volume

Todays L/H

Hadrien MendoncaIIFL

Dr Reddy’s Laboratories has been trading in a tight trading range for the past five weeks and has finally broken out from a consolidation pattern on the daily chart.

During the consolidation phase, the stock has convincingly managed to sustain above its crucial 50-DEMA support zone. Other momentum oscillators indicate that the stock has the potential to move higher towards its target of Rs 2822 in the near-term.

(The author is a Senior Technical Analyst, IIFL)

Disclaimer: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol Contributor

first published: Jan 25, 2019 11:17 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347